Telehealth company Hims & Hers has launched its direct-to-consumer weight-loss therapy channel in the UK, offering GLP-1 agonists like Novo Nordisk’s Wegovy at a starting price of £149 per month. The move also marks the launch in the UK of the Hers part of the Hims & Hers business, which until now has focused mainly…
Prostate cancer screening should not be made available to the vast majority of men across the UK, according to a committee set up to recommend a screening policy for the health service. Rather, the UK National Screening Committee (NSC) has recommended a targeted approach, only for men with a confirmed BRCA1 or BRCA2 gene variant…
Risk-Based, Centralized Screening may Improve Osteoporosis Care in Men: JAMA We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link